CSI is dedicated to promoting development in the field of congenital, structural and valvar heart disease interventions worldwide. Lead by experts in the field, CSI supports and promotes global and multidisciplinary collaboration by providing educational conferences, workshops and online learning opportunities. It is our goal to stay at the forefront of technology, innovation and medical device development and we achieve this through close collaboration with our worldwide network of physicians, healthcare providers and industry professional
The focus of each presentation should cover the unmet clinical need addressed, the feasibility of the technology, preclinical testing completed or planned, regulatory pathways and commercialization options.
MAXIS Medical, in collaboration with the moderators and the panelists, will be providing the startup selected a prize of €5,000 and 30 hours of startup consulting services for the MAXIS CSI Innovator Award.
Award Criteria:
- Clear and large unmet clinical need
- Proposed solution/device/technology
- Existing market/competition/barriers to market entry
- Intellectual property status
- Current and proposed/future funding
- Regulatory pathways
- Milestones
Submission deadline – Friday, December 2, 2022
